In the context of pediatrics, miR-34a has garnered attention due to its potential role in the development and progression of several pediatric conditions. For instance, it has been implicated in pediatric cancers like neuroblastoma and medulloblastoma. Its dysregulation may also contribute to congenital anomalies and developmental disorders.
